The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- Revolutionizing Dental Restorations: Pacdent’s Rodin Sculpture 2.0
- From Niche to Global Leader: 5 Strategies to Skyrocket Your Aligner Business to Outshine Invisalign
- Sprintray Acquires EnvisionTEC Dental Portfolio to Revolutionize 3D Printing in Dentistry
- Comprehensive Guide to Dental Splints in Neuromuscular Dentistry (NMD)
- GLP-1 Receptor Agonists and Oral Health: Essential Insights for Dentists
Archives